Skip to content

Clinical trials

Phase 2 Adenocarcinoma trials in Hungary

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma Phase: Phase 2 Country / region: Hungary Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20081
20091
20121
20152
20181
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Terminated2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Elevation Oncology1
European Organisation for Research and Treatment of Cancer - EORTC1
Maia Biotechnology1
MediGene1
Merck Sharp & Dohme LLC1
NantBioScience, Inc.1
NantCell, Inc.1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma8
Carcinoma, Non-Small-Cell Lung3
Neoplasm Metastasis2
Pancreatic Neoplasms2
Bulbo-Spinal Atrophy, X-Linked1
Carcinoma1
Carcinoma, Large Cell1
Carcinoma, Renal Cell1
Carcinoma, Squamous Cell1
Colonic Neoplasms1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.